{"abstract":"The Food and Drug Administration (FDA) is correcting a final rule entitled \"Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs\" that appeared in the Federal Register of August 31, 2016 (81 FR 60169). That final rule amended current regulations concerning who must register establishments and list human drugs, human drugs that are also biological products, and animal drugs. The final rule was published with an incorrect statement in the preamble about the rule's effect on establishments at which investigational drugs are manufactured. This document corrects that error.","action":"Final rule; correction.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/12/13/2016-29774.html","cfr_references":[{"chapter":null,"citation_url":null,"part":20,"title":21},{"chapter":null,"citation_url":null,"part":201,"title":21},{"chapter":null,"citation_url":null,"part":207,"title":21},{"chapter":null,"citation_url":null,"part":314,"title":21},{"chapter":null,"citation_url":null,"part":514,"title":21},{"chapter":null,"citation_url":null,"part":515,"title":21},{"chapter":null,"citation_url":null,"part":601,"title":21},{"chapter":null,"citation_url":null,"part":607,"title":21},{"chapter":null,"citation_url":null,"part":1271,"title":21}],"citation":"81 FR 89848","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Effective December 13, 2016.","disposition_notes":null,"docket_ids":["Docket No. FDA-2005-N-0464 (Formerly Docket No. 2005N-0403)"],"dockets":[],"document_number":"2016-29774","effective_on":"2016-12-13","end_page":89849,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/12/13/2016-29774.xml","html_url":"https://www.federalregister.gov/documents/2016/12/13/2016-29774/requirements-for-foreign-and-domestic-establishment-registration-and-listing-for-human-drugs","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-29774?publication_date=2016-12-13","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-12-13/2016-29774/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":817,"last_updated":"2026-11-22 16:15:03 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-12-13/pdf/2016-29774.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-29774.pdf?1481550341","publication_date":"2016-12-13","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/12/13/2016-29774.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Tab 5: Cost Impacts of the Over-the-Counter Pharmaceutical Labeling Rule - 03/05/1999 final report","document_id":"FDA-2005-N-0464-0243"},{"title":"Tab 4: Profile of the Prescription drug wholesaling Industry: Examination of Entities Defining Supply and Demand in Drug Distribution - Final Report dated on 02/12/2001","document_id":"FDA-2005-N-0464-0242"},{"title":"Tab 3: Draft Final Economic Impact Analysis for a Prospective FDA Rule Governing: Foreign and Domestic Establishment Registration and Listing Requirements for Human Drugs, Certain Biological Drugs, and Animal Drugs - on 08/03/2005","document_id":"FDA-2005-N-0464-0241"},{"title":"Tab 2: Letter from FDA/CDER to Eugene S. Peiser & Associates Dated on 08/25/1997","document_id":"FDA-2005-N-0464-0240"},{"title":"Tab 1: Letter from National Association of CHAIN DRUG STORES(NACDS) to FDA/CDER on 09/27/2004","document_id":"FDA-2005-N-0464-0239"},{"title":"Ref2_ERG Revisions 1995 DRAFT FINAL REPORT ECONOMIC THRESHOLD AND REGULATORY FLEXIBILITY ASSESSMENT OF PROPOSED CHANGES TO THE CURRENT GOOD MANUFACTURING PRACTICE REGULATIONS FOR MANUFACTURING, PROCESSING, PACKING, OR HOLDING DRUGS\n(21CFR210&211) re Requi","document_id":"FDA-2005-N-0464-0237"},{"title":"Ref1_BLS_wages_May_2014_NAICS325400 - Pharmaceutical and Medicine Manufacturing re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and ","document_id":"FDA-2005-N-0464-0236"},{"title":"Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that Are Regulated Under a Biologics License Application, and Animal Drugs","document_id":"FDA-2005-N-0464-0235"},{"title":"Shipping Label re Comment from Bristol-Myers Squibb Company","document_id":"FDA-2005-N-0464-0150"},{"title":"Background Material re The Compressed Gas Assaciation (CCA) and the Gases and Welding Distributors Association (GAWDA)","document_id":"FDA-2005-N-0464-0073"}],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2005-N-0464","supporting_documents_count":15,"docket_id":"FDA-2005-N-0464","regulation_id_number":null,"title":"Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs","checked_regulationsdotgov_at":"2017-01-02T06:00:20Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":89848,"subtype":null,"title":"Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Correction","toc_doc":"Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs Regulated under Biologics License Application, and Animal Drugs","toc_subject":null,"topics":[],"type":"Rule","volume":81}